Efficacy and Safety of Azilsartan in Participants With Mild to Moderate Uncomplicated Essential Hypertension
Status:
Completed
Trial end date:
2008-07-01
Target enrollment:
Participant gender:
Summary
The purpose of this study was to evaluate the dose-response relationships of azilsartan, once
daily (QD) in participants with mild to moderate uncomplicated essential hypertension.